Page 3 - Best Testicular cancer doctors: TOP 102 doctors

Dr. Dror Levin specializes in pediatric oncology, with a focus on bone cancer (sarcoma) in children at Sourasky Medical Center.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel Society of Pediatric Hematology and Oncology (ISPHO)
• Trained in bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Prof. Haim Matskin is a leading authority in onco-urology, specializing in testicular cancer treatment at Sourasky Medical Center.

• Heads the Urology Department at Sourasky Medical Center
• Expert in brachytherapy and cryotherapy for malignant tumors
• Member of the Medical Association of Israel and international urology associations

Dr. Avi Beri specializes in comprehensive urological treatments at Sourasky Medical Center, including prostatectomy and TURP.

• Expert in kidney stones treatment and vasectomy
• Provides urology consultations for various conditions
• Focuses on helping patients achieve a healthy life

Internationally recognized oncologist with over 22 years of experience of experience leading clinical divisions and research in targeted cancer therapies. He practices personalized medicine at Wiener Privatklinik.

• Expert in solid tumor oncology, especially breast and gynecologic cancers
• Associate Professor at the Medical University of Vienna, contributing to new treatment strategies
• Deputy Head of Clinical Division of Oncology, advancing translational cancer research
• Specializes in biomarker development and individualized systemic therapy

Prof. Jack Baniel leads urology at Rabin Medical Center, specializing in nerve-sparing cancer surgeries with robotic precision. He founded the oncourology department at Beilinson Hospital.

• Performs bladder reconstruction and robotic prostatectomy
• Published 100+ scientific articles on uro-oncology
• Member of European and American urology associations
• Involved in global clinical research collaborations

Associate Professor Dr. Yusuf Acikgoz brings international oncology expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in medical oncology with a focus on testicular cancer
• Participated in Phase III clinical trials like CheckMate-649 and Fortitude-101
• Certified in Good Clinical Practice and Human Subjects Protection
• Member of American Society of Clinical Oncology (ASCO)

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at multiple oncology clinics in Turkey
• Promoted to Associate Professor in 2016
• Studied at Selcuk University Faculty of Medicine

Professor Keil specializes in interventional radiology, using advanced imaging to guide precise treatments. Currently heads the Diagnostic and Interventional Radiology Clinic at Academic Hospital Solingen.

• Over 22 years of experience of experience in radiology and interventional procedures
• Expert in CT, MRI, and ultrasound-guided interventions for accurate diagnosis and treatment
• Former leading doctor at University Hospital of Aachen under renowned specialists
• Member of Germany's top radiology teams for complex cases

Chief Physician at a certified cancer center, Phd Viola Fox specializes in innovative treatments for testicular cancer.

• 14 years of experience of experience in oncology
• Expert in chemotherapy, immunotherapy, and targeted therapy
• Qualified specialist in genetics for personalized treatment plans
• Active member of German and American cancer research societies

Professor Cemil Bilir brings over 21 years of experience of specialized experience in medical oncology, with training at top institutions like Cleveland Clinic and Northeastern University.

• Specializes in treating testicular cancer using the latest protocols
• Member of ASCO and ESMO – stays current with global standards
• Teaches future oncologists as a professor at Sakarya University
• Completed fellowship at Northeastern University's Center for Pharmaceutical Biotechnology

49 years of experience specializing in virotherapy – Dr. Jaunalksne leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.

• Graduate of Riga Medical Institute with an internship in Internal Medicine
• Head of Clinical Immunology Center – oversees cutting-edge immunology treatments
• Focuses on innovative virotherapy approaches for cancer treatment

Dr. Ozden brings over 27 years of experience of experience in internal medicine and medical oncology, specializing in testicular cancer at VM Medical Park Pendik Hospital.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital
• Graduated from Istanbul University, Cerrahpaşa Faculty of Medicine

Associate Professor Nail Paksoy specializes in testicular cancer treatment, with a medical oncology fellowship from Istanbul University and ESMO Board Certification.

• Participated in 8 international clinical trials for cancer treatments
• Published multiple studies on metastatic cancers in peer-reviewed journals
• Member of the European Society for Medical Oncology (ESMO)

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Joseba Rebollo Liceaga brings over 36 years of experience of oncology experience, specializing in testicular cancer at Quironsalud Torrevieja.

• Head of Oncology at Clínica San Miguel de Navarra for 36 years of experience
• Specialist in Medical Oncology from Clínica Universidad de Navarra
• Authored research on electrochemotherapy and multidisciplinary treatments
• Currently practices at Quirónsalud Alicante

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.